NovaBay Pharmaceuticals Inc (NBY) 配当

Q: NovaBay Pharmaceuticals Incの現在の配当金と年間配当金はいくらですか？

NovaBay Pharmaceuticals Incが現在支払う配当金は$0.80です。NovaBay Pharmaceuticals Incの年間配当金は$0.00です。

Q: NovaBay Pharmaceuticals Incの配当性向は何ですか？

NovaBay Pharmaceuticals Incの配当性向は0.00%です。

Q: NBYの配当落ち日はいつですか？

NovaBay Pharmaceuticals Incの配当落ち日はSep 30, 2025です。

Q: NovaBay Pharmaceuticals Incはどのくらいの頻度で配当金を支払いますか？

四半期ごと。NovaBay Pharmaceuticals Incが最後に配当金を支払ったのはSep 29, 2025です。

ホーム

株式

NBY

NBY 配当

NovaBay Pharmaceuticals Inc

$14.77

16.39%

$2.08

終値： Jan 16, 16:00:00 GMT-5

$12.91

-12.59%

$-1.85

アフターマーケット：Jan 16, 20:00:00 GMT-5

概要予測収入配当財務状況

主要データ

前終値

$12.69

始値

$12.3

当日レンジ

$11.91 - $18.4

52週レンジ

$0.46 - $19.95

取引高

2.7M

平均取引高

1.2M

1株当たり利益(TTM)

-6.62

配当利回り

時価総額

$1.6B

NBYとは何ですか？

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.

特徴

取引戦略